Aditxt, Inc. Sale Leaseback Transaction, Net Book Value
Aditxt, Inc. (ADTX) had Sale Leaseback Transaction, Net Book Value of $20.00 million as of 2024-02-16, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Leases
us-gaap:SaleLeasebackTransactionNetBookValue · last filed 2025-05-15
- 2024-02-16: Sale Leaseback Transaction, Net Book Value $20.00M.
| Period end | Sale Leaseback Transaction, Net Book Value |
|---|---|
| 2024-02-16 | $20.00M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |